Diabetes-Related Blindness, Renal Failure Can Be Reduced

October 31, 1997

ANN ARBOR--- People who develop type 2 diabetes at an early age can substantially reduce their rates of blindness and kidney failure in later life by tightly controlling their blood-sugar level, according to researchers at the University of Michigan Medical Center and the Veterans Administration Medical Center in Ann Arbor.

Those who get diabetes later in life, however, may gain only small benefits from tight control and may well choose not to undergo the difficult treatment regimens needed to achieve it.

The research findings will be published in the Nov. 1 issue of the Annals of Internal Medicine.

Approximately nine out of 10 diabetics have type 2 diabetes, which means their pancreases produce some insulin, but not enough to meet their needs.

Previous research demonstrated that intensive medical treatment has substantial benefits for people with type 1 diabetes---so called "juvenile-onset" diabetes---but the value of tight control of blood-sugar in type 2 diabetics has been more controversial.

In the United States, about 8 million people are diagnosed with diabetes, which is the No. 1 cause of blindness, renal failure and amputation in industrialized nations.

The research suggests how those devastating complications might be reduced.

People who develop type 2 diabetes at a relatively early age---before age 50 to 55, for example---are at far greater risk of ultimately losing their vision and kidney function than those whom the disease strikes later. If people with early onset of type 2 diabetes can maintain a near-normal blood-sugar level, however, their lifetime risk of diabetes-related blindness will be significantly decreased, the researchers found.

"We need to devote more attention to this high-risk group," said Rodney Hayward, M.D., associate professor of medicine and public health at the U-M Medical Center and director of the Center for Practice Management & Outcomes Research at the VA Medical Center in Ann Arbor. "Much of the high cost of diabetes---in both human suffering and dollars and cents---is due to complications which could have been prevented early on."

For patients in one health maintenance organization the researchers studied, in fact, intensified medical care for less than 20 percent of all diabetics---those at the highest risk---could eliminate more than 80 percent of the preventable blindness.

"It is important to note, however, that about half of diabetics get diabetes after age 60, and they are generally at low risk of complications if they maintain moderate blood sugar control," said Sandeep Vijan, M.D., the lead investigator on the project and an Agency for Health Care Policy & Research fellow at the time the research was conducted. Although strict blood sugar control would further reduce risk for those with late-onset diabetes, the benefits would be small---generally decreasing the risk of complications by less than one in 100.

In addition, Vijan said, it often is difficult to achieve strict blood sugar control. "Several new medications can help most type 2 diabetics maintain moderate control of their blood-sugar level without the use of insulin," he said. "However, high-risk patients, those who require tight blood sugar control to reduce future health complications, often will need insulin therapy and closer monitoring and more medical attention than most diabetics typically receive today."

That, the researchers point out, creates a policy issue for the government and insurance companies.

The research was supported by the Department of Veterans Affairs and the Agency for Health Care Policy & Research. Vijan and Hayward conducted the research with Timothy Hofer, M.D.

# # # # # #


University of Michigan

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.